Winston-Salem, NC—Postbiotics, Inc. and Sabinsa Corporation shared the news of a multinational distribution agreement that includes the U.S., Canada, European Union, India, Japan, and other significant markets for the dietary supplement and functional food ingredient PoZibio.
About PoZibio
- Formulated for age-related digestive health conditions including Leaky Gut Syndrome (LGS), which is associated with occasional symptoms of irregularity, diarrhea, gas, bloating, fatigue, age-related cognitive decline, metabolism and muscle health, decreased immunity, and decreased GLP-1 production.
- Patent-protected postbiotic composition of Lipoteichoic Acid, isolated from the cell walls of a heat-treated strain of Lactobacillus paracasei (Patent Number US 11,622,981 B2).
- Discovered by gut microbiome longevity researchers at the Wake Forest University College of Medicine
- Suitable for use in functional foods, medical foods, and dietary supplements due to its low dose, heat stability, and neutral taste profile.
- Generally Regarded as Safe (GRAS) and non-GMO PoZibio.
Expanding on the benefits, Hariom Yadav, Ph.D., Associate Professor of Neurosurgery and Brain Repair and Director of University of South Florida’s Center for Microbiome Research, who discovered PoZibio while at Wake Forest, stated: “The gut-brain axis benefits we have shown from PoZibio are compelling. PoZibio has been shown to increase the mucous layer of the gut wall, inhibit age-related inflammation (inflammaging), support cognitive function, and promote muscle and metabolic health, in prior and ongoing research.”
Primed for innovation
“I’m pleased to bring forth an ingredient for a condition that is very under addressed in the marketplace," shared Shaheen Majeed, Global CEO & Managing Director of Sabinsa, in the announcement. "Additionally, this marks one of the very first partnerships Sabinsa enters into globally, and at its core represents the best of science and functionality.”
Doug Lynch, Co-founding Partner and Chief Commercial Officer of Postbiotics, Inc., added, “We are pleased to be working with Sabinsa, and believe their global sales organization and manufacturing prowess are perfect complements to our world-class research. This distribution partnership with Sabinsa will ensure consumer brands of supplements and foods in the United States and beyond will experience the many benefits from postbiotics on improving health and lifespan."
